Thus, CD4+ T cells help initiate a gene expression program in CD8+ T cells that enhances CTL function by improving their migratory potential and downregulating the expression of their co-inhibitory receptors resulting in increased antitumor efficacy of cancer therapeutic vaccination. Here, CD8A is linked to cancer.